Department of Health Systems and Policy, School of Public Health and Family Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi.
Malawi College of Health Sciences, Blantyre, Malawi.
BMC Public Health. 2022 Aug 15;22(1):1552. doi: 10.1186/s12889-022-13974-4.
HIV status disclosure is one of the pillars of success of the elimination of Mother to Child Transmission of HIV (eMTCT) program. However, there are challenges associated with it that limit full disclosure. Literature shows that for pregnant women in developing countries, who have been diagnosed with HIV, 16% to 86% disclose their status to their sexual partners. This study explored the experiences of newly diagnosed HIV-infected antenatal women in disclosing their HIV status to their male sexual partners in Blantyre, Malawi.
This was a qualitative explanatory multiple case study that was conducted from 2018 to 2019 using in-depth interviews and diaries as data collection tools. We recruited seven newly diagnosed HIV pregnant women who had not disclosed their status to their male sexual partners and were initiated on Option B + strategy of the eMTCT of HIV at Limbe Health Centre. The investigator had 3 contacts with each participant from which data was gathered except for one participant who got lost to follow-up. This study employed content analysis and used a within-case and across-case analysis.
Women either use facilitated mutual disclosure process or disclosed directly to their male sexual partners. Women were motivated to disclose because they wanted an HIV-free baby, to know the partners' status, and to resolve the gap on how they got infected with HIV. The disclosure process faced challenges such as uncertainty about a partner's reaction after disclosure, fear of relationship dissolution, and the soberness of the partner. Privacy was an important consideration during the process of disclosure. Following disclosure, male sexual partners either accepted the status immediately after disclosure or initially denied but later accepted.
This study has shown that newly diagnosed HIV pregnant women accessing eMTCT services have a plan of either to disclose or conceal their HIV status from their male sexual partner and this decision is affected by the nature of relationship that exist between them and their partner. Factors relating to the unborn baby, the relationship as well as to know partners status motivate women to either disclose or conceal.
艾滋病毒状况披露是消除艾滋病毒母婴传播(eMTCT)项目成功的支柱之一。然而,与艾滋病毒状况披露相关的挑战限制了完全披露。文献表明,在发展中国家,被诊断出艾滋病毒的孕妇中,有 16%至 86%向其性伴侣披露了自己的艾滋病毒状况。本研究探讨了马拉维布兰太尔新诊断出艾滋病毒感染的产前妇女向其男性性伴侣披露艾滋病毒状况的经验。
这是一项定性解释性多案例研究,于 2018 年至 2019 年期间使用深入访谈和日记作为数据收集工具进行。我们招募了七名尚未向其男性性伴侣披露艾滋病毒状况且已开始接受艾滋病毒母婴传播 Option B+策略的新诊断出艾滋病毒感染的孕妇。调查员与每位参与者进行了 3 次接触,从中收集了数据,只有一位参与者失去了随访。本研究采用内容分析,并进行了案例内和跨案例分析。
妇女要么使用促进的共同披露过程,要么直接向其男性性伴侣披露。妇女之所以选择披露,是因为她们想要一个没有艾滋病毒的婴儿,了解伴侣的状况,并解决她们如何感染艾滋病毒的差距。披露过程面临一些挑战,例如不确定伴侣在披露后的反应、对关系破裂的恐惧以及伴侣的清醒。披露过程中隐私是一个重要的考虑因素。披露后,男性性伴侣要么在披露后立即接受,要么最初否认但后来接受。
本研究表明,接受母婴传播 eMTCT 服务的新诊断出艾滋病毒感染的孕妇有计划向其男性性伴侣披露或隐瞒其艾滋病毒状况,而这一决定受到他们与伴侣之间关系性质的影响。与未出生婴儿、关系以及了解伴侣状况相关的因素促使妇女进行披露或隐瞒。